Epsom Salt Granule
NDC Package 67091-352-04
Package Information
Epsom Salt (magnesium sulfate) granules is do not exceed more than 2 doses per day; if necessary repeat dosage in 4 hoursagedose adults and children 12 years and older 2-4 level teaspoons dissolved in a full glass (8oz) of water children 6 to 11 years1-2 level teaspoons dissolved in a full glass (8oz) of waterNot recommended for children under 6 years of age. This formulation utilizes a granule delivery system. Marketed by Winco Foods, Llc, this product is identified by NDC 67091-352 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 1053346 - Epsom salt 100 % Granules for Oral Solution
- RxCUI: 1053346 - magnesium sulfate 1000 MG Granules for Oral Solution
- RxCUI: 1053346 - magnesium sulfate 100 % Granules for Oral Solution
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 67091 - Winco Foods, Llc
- 67091-352 - Epsom Salt
- 67091-352-04 - 1.81 g in 1 POUCH
- 67091-352 - Epsom Salt
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67091-352-04 identifies a specific commercial package of 1.81 g in 1 pouch of Epsom Salt, a human over the counter drug labeled by Winco Foods, Llc. This granule is formulated for oral; topical use and contains magnesium sulfate, unspecified as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Winco Foods, Llc on July 01, 2018. The current certification is valid through December 31, 2026.
How is this Winco Foods, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67091035204. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.